EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sturge–Weber Syndrome: A Narrative Review of Clinical Presentation and Updates on Management

Aarnav D Shah, Peter Alexieff, Priyamvada Tatachar iD

Journal of Clinical Medicine · 22.03.2025 · 14 (7) · 2182

DOI: 10.3390/jcm14072182 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.03.2025. Verfasst von Aarnav D Shah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lake Forest Academy, Lake Forest, IL 60045, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sturge–Weber Syndrome (SWS) is a rare neurocutaneous disorder caused by a somatic nonsynonymous mosaic mutation most commonly in the GNAQ gene (G protein guanine Nucleotide-binding protein Alpha subunit q). SWS is characterized by capillary-venous malformations in the brain and eyes and a characteristic facial port wine (PW) birthmark (previously called port wine stain/PWS) in the head/neck region. Clinical manifestations vary and include epilepsy, stroke-like episodes, migraine headaches, cognitive delays, glaucoma, ocular vascular anomalies, heterochromia of the iris, visual field defects, and endocrine disorders like growth hormone deficiency or central hypothyroidism. The pathognomonic findings seen in neuroimaging with magnetic resonance imaging (MRI) include the presence of unilateral intracranial leptomeningeal angiomatosis, typically ipsilateral to the facial birthmark. SWS does not currently have a definitive cure, and management strategies focus on symptomatic management such as anti-seizure medications, limited surgical resection of the epileptogenic tissue or hemispherectomy for cases of drug-resistant epilepsy (DRE), selective photo-thermolysis of the PWS using a pulsed dye laser, and the medical and/or surgical management of glaucoma. In addition to these symptomatic treatments, the use of preventive, modifying, or stabilizing treatments like low-dose aspirin in reducing the frequency and severity of seizures and stroke-like events and the use of newer therapies like cannabidiols and mTOR inhibitors are being reviewed and have shown promising early results. This comprehensive narrative review summarizes the current literature on clinical management strategies, ongoing research studies, and future directions in the diagnosis and management of SWS.

Schlagwörter

Stichwörter der Autor:innen

Sturge–Weber syndromedrug-resistant epilepsyglaucomahemispherectomyport wine birthmark

Autor:innen und Institutionen

  • Lake Forest Academy, Lake Forest, IL 60045, USA.
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

ORCID-Profile: Priyamvada Tatachar

Zitieren

APA

Shah, A. D., Alexieff, P., & Tatachar, P. (2025). Sturge–Weber Syndrome: A Narrative Review of Clinical Presentation and Updates on Management. Journal of Clinical Medicine, 14(7), 2182. https://doi.org/10.3390/jcm14072182

Vancouver

Shah AD, Alexieff P, Tatachar P. Sturge–Weber Syndrome: A Narrative Review of Clinical Presentation and Updates on Management. Journal of Clinical Medicine. 2025;14(7):2182. doi:10.3390/jcm14072182

BibTeX
@article{Shah2025,
  author = {Shah, Aarnav D and Alexieff, Peter and Tatachar, Priyamvada},
  title = {Sturge–Weber Syndrome: A Narrative Review of Clinical Presentation and Updates on Management},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {2182},
  doi = {10.3390/jcm14072182}
}
Kostenlos starten →